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AbstrACt
Objectives To assess the effect of using a treatment 
escalation/limitation plan (TELP) on the frequency of 
harms in 300 patients who died following admission to 
hospital.
Design A retrospective case note review of 300 
unselected, consecutive deaths comprising: (1) 
patients with a TELP in addition to a do-not-attempt 
cardiopulmonary resuscitation order (DNACPR); (2) those 
with DNACPR only; and (3) those with neither. Patient 
deaths were classified retrospectively as ‘expected’ 
or ‘unexpected’ using the Gold Standard Framework 
Prognostic Indicator Guidance.
setting Medical, surgical and intensive care units of a 
district general hospital.
Outcomes The primary outcome was the between-group 
difference in rates of harms, non-beneficial interventions 
(NBIs) and clinical ‘problems’ identified using the 
Structured Judgement Review Method.
results 289 case records were evaluable. 155 had a 
TELP and DNACPR (54%); 113 had DNACPR only (39%); 
21 had neither (7%). 247 deaths (86%) were ‘expected’. 
Among patients with ‘expected’ deaths and using the 
TELP/DNACPR as controls (incidence rate ratio (IRR)=1.00), 
the IRRs were: for harms, 2.99 (DNACPR only) and 4.00 
(neither TELP nor DNACPR) (p<0.001 for both); for NBIs, 
the corresponding IRRs were 2.23 (DNACPR only) and 
2.20 (neither) (p<0.001 and p<0.005, respectively); 
for ‘problems’, 2.30 (DNACPR only) and 2.76 (neither) 
(p<0.001 for both). The rates of harms, NBIs and 
‘problems’ were significantly lower in the group with a 
TELP/DNACPR compared with ‘DNACPR only’ and ‘neither’: 
harms (per 1000 bed days) 17.1, 76.9 (p<0.001) and 
197.8 (p<0.001) respectively; NBIs: 27.4, 92.1 (p<0.001) 
and 172.4 (p<0.001); and ‘problems’: 42.3, 146.2 
(p<0.01) and 333.3 (p<0.001).
Conclusions The use of a TELP was associated with a 
significant reduction in harms, NBIs and ‘problems’ in 
patients admitted acutely and who subsequently died, 
especially if they were likely to be in the last year of life.
IntrODuCtIOn 
Around 30% of patients admitted to acute 
hospitals in Scotland are in the last year of 
life, and nearly 10% die during the index 
admission.1 In all, nearly 30 000 patients die 
in Scottish hospitals per annum, representing 
just over half of all deaths.2 However, treating 
hospital patients who are on an end-of-life 
trajectory in the same way as those who have a 
reversible cause for their illness may not only 
be futile3 but also harmful and costly.4 5 
Unrealistic societal expectations and 
professional incentives often drive a ‘fix 
it’ approach to treating acute illness that 
disregards context and prognosis. The pres-
sures to do so are multiple, powerful and 
entrenched.6 As a consequence, non-benefi-
cial interventions (NBIs) are commonplace. 
For example, in patients admitted with frac-
ture neck of femur, many of whom are in 
strengths and limitations of this study
 ► Gold Standards Framework criteria and the 
Structured Judgement Review Method were used to 
evaluate the context of each patient’s illness and the 
important outcomes of clinical decision making and 
treatment.
 ► Our study adds to existing evidence regarding the 
advantages of treatment escalation/limitation plans 
in patients who are critically ill and potentially near-
ing the end of life.
 ► Case note reviews were unavoidably unblinded, and 
reviewer bias was possible in determining the key 
outcome measures.
 ► The study did not include patients who survived crit-
ical illness and this may limit the generalisability of 
the study conclusions.
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the last year of life, in-hospital mortality is significant 
(5%–15%) and often related to preoperative comorbid-
ities. The ‘fix it’ approach to managing the fracture (an 
intervention that is almost always appropriate) is often 
applied to post-operative complications (sometimes 
inappropriate).7
In a recent systematic review comprising data from 
38 studies in 1.2 million patients, Cardona-Morrell et al 
reported that between 31% and 38% of major medical 
interventions were non-beneficial in patients in the last 
year of life.8 Further, whether treatments are beneficial or 
not, all treatments are associated with risks, and a propor-
tion will eventually culminate in harm. Harms include 
not only physical but also psychological and spiritual 
elements. NBIs can perpetuate illusions of recovery, are 
wasteful of resources and often have a negative impact on 
families5 and professional staff as well as patients.9
Avoiding inappropriate overinvestigation and over-
treatment, as well as undertreatment of palliative care 
needs, is key to delivering better care.10 These concepts 
are central to Realistic Medicine11 and Choosing Wisely.12 
One well-established method of avoiding a futile and 
potentially harmful intervention is the do-not-attempt 
cardiopulmonary resuscitation order (DNACPR). This 
addresses the inappropriateness of CPR in the context 
of an expected natural death. Although the scope of 
DNACPR is on the face of it limited to one particular 
intervention, evidence has emerged that its use is unin-
tentionally broader. Some health professionals as well as 
members of the public interpret ‘DNACPR’ as a surro-
gate for withholding other treatments.13 14 The difficulties 
associated with DNACPR highlight the need for a more 
appropriate tool that facilitates personalised treatment 
escalation/limitation decisions and communicates them 
effectively.
Treatment escalation/limitation plans (TELPs) have 
been developed to minimise the risk of harm by setting 
individualised boundaries for treatment in the event 
of deterioration in the patient’s clinical status. They 
facilitate the avoidance of treatments that are ‘futile, 
burdensome or contrary to a patient’s wishes’. A TELP 
also addresses the issue of discontinuity of care that 
often adversely influences patient management at times 
of acute deterioration. The TELP is a communication 
tool that summarises goals as well as limitations of treat-
ment for patients who are unstable or nearing the end 
of life. The goals of care, including resuscitation status, 
are based on assessing a patient’s diagnosis(es) and their 
illness trajectory, the reversibility of acute deterioration 
and the patient’s preferences and wishes. A completed 
TELP is filed at the front of the patient’s notes for ease 
of access, particularly for staff working out of hours and 
at weekends.
Various TELPs are being used in the UK14 15 and a 
national version is being developed.14 16 Among the first 
was the Universal Form of Treatment Options (UFTO) 
developed by Fritz and Fuld.17 These authors reported 
that using the UFTO was associated with a significant 
reduction in medical harms, notably those that contrib-
uted to death, compared with using DNACPR alone.
AIms
The aim of the present study was to evaluate the effect of 
a TELP on harms, NBIs and ‘problems’,18 19 in patients 
during their last admission leading to in-hospital death. 
These were identified using the Structured Judgement 
Review Method (SJRM) and based on reviewers’ judge-
ments about treatment/care considered to be poor or 
very poor or had the potential to have a negative impact 
on patient safety.18
methODs
The study compared the frequency of harms, NBIs and 
clinical ‘problems’18 19 in 300 consecutive patients who 
were admitted acutely and subsequently died in Univer-
sity Hospital, Hairmyres, between February and May 
2017. Patients were included regardless of their age and 
preadmission clinical status. Patients who died in the 
emergency department were excluded.
Cases were allocated to one of three groups:
Group 1: those who had both a DNACPR and a TELP.
Group 2: those who had a DNACPR only.
Group 3: those with neither a DNACPR nor a TELP.
The decision to use either a TELP or a DNACPR order 
was at the discretion of the clinical teams responsible for 
each patient’s care and was not obligatory. In each case, 
the DNACPR/TELP was initiated by the lead consul-
tant or was required to be endorsed by him/her within 
24 hours.
Group allocation was determined by examining each 
patient’s clinical record and checking for DNACPR and 
TELP completion.
Reviewers assessed whether each patient’s death was 
‘expected’ or ‘unexpected’ using a modification of the 
Gold Standard Framework (GSF) Prognostic Indicator 
Guidance (PIG).20 The PIG is based on the General 
Medical Council  (UK) 2010 definition of patients ‘likely 
to die within the next 12 months’. The criteria used to 
identify an ‘expected’ death are listed in table 1. However, 
only two of the three recommended triggers were used: 
the ‘Surprise Question’ was considered inappropriate in 
a retrospective mortality case note review.
study end-points
Detailed case note review was undertaken to identify 
specific clinical ‘problems’, using an adaptation of the 
SJRM used in the National Mortality Case Record Review 
Programme18 (see online supplementary appendix A and 
table 2 (column 2, ‘Examples’).
For each identified ‘problem’, the reviewers then 
judged whether it was associated with NBIs and/or 
whether harms had occurred (answering either yes, no 
or possibly). NBI was defined as a treatment undertaken 
or continued with the intention of stabilising or reversing 
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the patient’s clinical status but failing to do so. These did 
not include comfort measures. A harm was defined as an 
identifiable event resulting from treatment overuse or 
underuse, or where the potential benefits of an interven-
tion were significantly outweighed by detriment.
Qualitative assessment of each case was undertaken 
using comments sections in the data collection form 
(see online supplementary appendix A). Data collection 
was approved by the NHS Lanarkshire Quality Improve-
ment department.
Case reviewers and quality control 
The principal authors (CJL and DRT) were assisted by 
two co-reviewers (HKO and AR) who had previous experi-
ence with mortality casenote reviews. Independent dupli-
cate reviews were undertaken for 20% of cases. Kappa 
scores for inter-rater agreement were calculated. If there 
were any important disagreements, these were discussed 
and resolved prior to final analysis.
Outcomes and statistical analyses
The primary outcome measure was medical harms. The 
secondary outcomes were NBIs and SJRM ‘problems’.
Analyses were undertaken to determine whether there 
was a significant difference in the rates of harms between 
the three study groups. The secondary outcomes were 
analysed similarly. Chi-squared tests were used to test 
differences in proportions. Models were fitted using 
Poisson regression to test the difference in rates. The 
coefficients of Poisson regression are logs of the incidence 
rate ratios (IRRs). The group comprising patients who 
had both a TELP and DNACPR was used as the control 
group. The models were fitted first with the groups as 
independent variables, and then again with adjustments 
for sex, age, ward location, ‘expected’/’unexpected’ 
death and time from admission to death.
Power calculation and ethical approval
Online statistical software was used to generate a power 
calculation. Given an α of 0.05, a sample of 98 patients 
per group was needed to provide 80% power to detect an 
absolute difference of 30% between each group.
As this study comprised a retrospective case note review, 
ethics committee approval was not required. All data were 
anonymised.
treatment escalation/limitation plan
The TELP used in NHS Lanarkshire hospitals (known 
locally as the Hospital Anticipatory Care Plan) is provided 
in online supplementary appendix B. The TELP was 
introduced across all acute medical, surgical, intensive 
care and Care of the Elderly units in University Hospital 
Hairmyres during 2015. Training and education included 
one-to-one coaching sessions (provided by DRT) to all 
relevant consultants on the topics of futility, medical 
harms and prognostic conversations as well as using the 
TELP. A specific training video was widely distributed to 
trainee doctors and nursing staff.21
Patient and public involvement
Patients and members of the public were not involved in 
the design of this study.
results 
In total, there were 301 consecutive deaths (6.5% of 4604 
admissions during the specified period). Full hospital 
records were available for 289. Duplicate reviews were 
undertaken in 60 cases. The inter-rater agreement (Kappa 
score) was 0.74 for reviewer 1 versus 2, 0.78 for reviewer 1 
versus 3 and 0.85 for reviewer 1 versus 4.
Of the 289 deaths, 145 were men and 144 women 
(table 3). Their mean age at death was 78.3 years (range 
29–100). Seventy-four per cent of deaths occurred in 
medical areas, 18% in surgical areas and 8% in the inten-
sive care or high dependency units. The mean time to 
death following admission was 15.3 days (range 1–225). 
Using GSF criteria,20 247 deaths (85.5%) were retrospec-
tively deemed to have been ‘expected’.
In all, 155 patients (53%) had both a TELP and 
a DNACPR order, 113 (40%) had a DNACPR order 
only and 21 patients (7%) had neither.
In patients with ‘expected’ deaths, the TELP was 
endorsed a mean of 11.3 days (SD 19.4) after admission 
and 7.9 days (SD 10.7) prior to death. DNACPR was docu-
mented on average 5.5 days (SD 11.1) after admission 
and 11.5 days (SD 19.6) prior to death.
The frequencies and rates of harms, NBIs and clinical 
‘problems’ for each of the three study groups are shown 
in table 4. The IRR for harms comparing patients who had 
Table 1 Gold Standard Framework Prognostic Indicator Guidance criteria
Gold Standard 
Framework 
Prognostic 
Indicators for an 
‘expected’ death
 ► Acute life-threatening conditions presenting as sudden catastrophic events (death likely within a few 
hours or days).
 ► Advanced, progressive, incurable conditions that suggest a life expectancy of 12 months or less.
 ► General frailty with or without declining performance status that suggest a life expectancy of 12 months 
or less.
 ► Existing conditions that confer an increased risk of dying from acute deterioration in their health.
Triggers  ► The Surprise Question: ‘Would you be surprised if this patient were to die in the next few months, 
weeks, days’? (This trigger was not used in the context of a retrospective review).
 ► General indicators of decline—deterioration, increasing need or choice for no further active care.
 ► Specific indicators related to principal medical diagnoses (outlined in the Guidance document).
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both a TELP and DNACPR (IRR=1.00) and those with 
DNACPR only was 2.77 (95% CI 1.96 to 3.92, p<0.001). 
The corresponding value for those with neither TELP nor 
DNACPR was 2.61 (95% CI 1.50 to 4.55, p<0.001). For 
NBIs, the IRR for DNACPR only was 1.98 (95% CI 1.48 
to 2.64) and 1.44 (95% CI 0.83 to 2.50) for neither. The 
corresponding values for ‘problems’ were 2.04 (95% CI 
1.62 to 2.58) for DNACPR only and 1.78 (95% CI 1.19 
to 2.68) (p<0.001 and p<0.001, respectively) for neither. 
Further analyses excluding ‘unexpected’ deaths showed 
similar results: the IRRs were 2.99 (95% CI 2.10 to 4.28) 
(DNACPR only) and 4.01 (95% CI 2.30 to 6.99) (neither) 
for harms (p<0.001 for both); 2.23 (95% CI 1.66 to 3.00) 
and 2.20 (95%CI 1.26 to 3.83) for NBIs (p<0.001 and 
p<0.005, respectively); and 2.30 (95% CI 1.82 to 2.91) and 
2.76 (95% CI 1.84 to 4.15) for ‘problems’ (p<0.001 for 
both).
Adjustments for age, sex, ward location and ‘expect-
ed’/‘unexpected’ death (as determined retrospectively 
using GSF) did not substantially change the results. When 
Table 2 Rate of individual clinical ‘problems’ (per 1000 patient days) in 247 patients with ‘expected’ deaths (using Gold 
Standard Framework20) in University Hospital, Hairmyres during their last hospital admission prior to death, categorised using 
an adaptation of the Structured Judgement Review Method18
Description of clinical 
‘problem’ using structured 
judgement review Examples
All 
patients
TELP and 
DNACPR
DNACPR 
only
Neither TELP 
nor DNACPR
1 Assessment, 
investigation or 
diagnosis
An arterial blood gas taken that did not 
result in a change in management.
A delay in making a diagnosis or 
missing one altogether.
12.5 6.7 25.2* 34.8*
2 Medication/
intravenous fluids/
electrolytes/ oxygen
Intravenous fluids given when they were 
not indicated/required.
Side effects arising from unnecessary 
intravenous antibiotic therapy.
19.5 12.6 33.9* 58.0*
3 Treatment and 
management plan
Escalation in level of a patient’s care 
when they were dying.
Ambiguity regarding whether the patient 
was for active or palliative care.
21.3 11.5 40.0* 92.8*
4 Palliative or end-of-
life care
Documentation of end-of-life 
symptoms, for example, breathlessness, 
without evidence of these being treated.
Documentation of psychological, social 
or spiritual distress without evidence of 
it being addressed.
15.8 7.8 33.9* 34.8*
5 Operation/invasive 
procedure
An operation carried out shortly before 
the patient died which had little or no 
potential for benefit.
Placement of central venous line which 
did not benefit the patient.
2.8 1.1 4.35* 34.8*
6 Clinical monitoring Delay in recognising or reacting to 
evidence of a deteriorating patient (Early 
Warning Score).
Monitoring continued and acted on 
when it was fully recognised that the 
patient was dying.
4.5 2.2 8.7* 23.2*
7 Resuscitation 
following a cardiac or 
respiratory arrest
CPR carried out when there was no 
chance of success.
Inappropriate ICU admission following 
an arrest.
2.8 0.4 4.3* 58.0*
8 Any other type not 
fitting the categories 
above
Patient coerced into receiving treatment 
against their wishes.
Distress experienced by family 
members/loved ones as a result of 
inappropriate care.
5.0 3.3 8.7* 11.6*
*P values all <0.01 for between-group comparisons using TELP/DNACPR group as controls.
CPR, cardiopulmonary resuscitation; DNACPR, do-not-attempt cardiopulmonary resuscitation; ICU, intensive care unit; TELP, treatment 
escalation/limitation plan.
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the time between admission and death was taken into 
account in the Poisson regression models, the differences 
between the three groups increased.
Data for each of the individual problem categories are 
shown in table 2. There were significant between-group 
differences in each of the eight domains.
DIsCussIOn
In this study, we demonstrated that the use of a TELP 
in addition to a standard DNACPR order was associated 
with a reduced frequency of harms especially in patients 
judged to be nearing the end of life, compared with using 
a DNACPR alone.
Avoiding treatment overuse (as well as underuse) is 
an important dimension in achieving optimum care for 
all patients, irrespective of their clinical status.22 Our 
study indicated that this goal can be facilitated using a 
TELP: there were significantly fewer instances of NBI 
when a TELP was used (table 4). Treatment underuse 
was explored indirectly using the Structured Judgement 
Review Method. Undertreatment of a patient’s pallia-
tive care needs in the two groups without a TELP was a 
frequent reason for there being a ‘problem’ (table 2, item 
4).23
Quality of care in critically ill patients who subsequently 
die is influenced by many complex factors. The apparent 
benefits of using the TELP is not simply explained on the 
basis of cause and effect. Perhaps a TELP helps to reduce 
the perception of uncertainty that often leads clinicians to 
make inappropriate decisions in critical illness. Anec-
dotally, the TELP appears to act as a permission-giving 
prompt in favour of modified care including earlier palli-
ative treatments in patients who are approaching the end 
of life.
Using the GSF PIG,20 we identified retrospectively 
that 86% of 289 patients in the study could reasonably 
be considered to have been on an end-of-life trajectory. 
This equated to 5% of all admissions. The GSF PIG has 
been recently validated in a hospital-based population.24 
The tool is largely based on assessing preadmission 
comorbidities, illness trajectory and performance status. 
Although 93% of our cases had a documented DNACPR, 
suggesting that prognostic elements were considered at 
least in part by most clinicians, the fact that the mean 
time from admission to DNACPR completion for patients 
with ‘expected’ death was 5.5 days indicates that recogni-
tion of the patient’s illness trajectory and prognosis was 
delayed. Learning to identify patients who may be in the 
last year of life is an important skill that needs to be more 
consistently applied in the acute setting.
Similarly, TELPs were completed in only 53% of the 
cases. The timing of TELP completion was delayed even 
further: the mean time from admission was 11.3 days. 
Ideally, both DNACPR and TELP should be completed 
concurrently and at an early stage during a hospital 
admission. Clinicians frequently cite uncertainty as the 
reason for not doing so. However, the fact that 86% of 
patients had an ‘expected’ death based on preadmission 
criteria provides evidence that both DNACPR and a TELP 
are needed and should be completed sooner rather than 
later.
The use of TELPs is still relatively new—in contrast to 
DNACPR which has been widely used over a long interval. 
Our TELP was introduced across the three major NHS 
Lanarkshire hospitals in 2015. An extensive education 
and awareness programme during 2016/7 has focused 
not just on pro forma development21 but on coaching 
and mentoring consultant clinicians with an emphasis on 
identifying futility,7 25 avoiding treatment overuse22 and 
non-beneficial treatments,8 and harms reduction as key 
background reasons for using the TELP. That programme 
also focused on ‘prognostic conversations’ to facilitate 
shared decision-making. Discussion with patients/family 
members is a key element in preparing any TELP and is 
Table 3 Patient demographics
All TELP+DNACPR DNACPR only Neither
Number of patients 289 155 113 21
Mean age at time of death (years, 
range)
78.6 (29–100) 79.7 (49–100) 78.1 (44–98) 73.1 (29–96)
Male 145 (50.1%) 73 (47.1%) 58 (51.3%) 14 (66.7%)
Female 144 (49.9%) 82 (52.9%) 55 (48.7%) 7 (33.3 %)
Location 
  Medical 216 (74.0%) 124 (79.8%) 83 (73.4%) 11 (52.3%) 
  Surgical 51 (18.0%) 28 (18.2%) 15 (13.3%) 7 (33.3 %) 
  ICU 22 (8.0%) 3 (2.0%) 15 (13.3%) 3 (14.3%)
Length of hospital stay (days (SD)) 15.3 (21.0) 18.7 (24.8) 12.5 (15.3) 5.5 (5.5)
‘Expected’ death* 247 (85.5%) 141 (91.0%) 93 (82.3%) 13 (51.9%) 
‘Unexpected’ death* 42 (14.5%) 14 (9.0%) 20 (17.7%) 8 (38.1%)
*based on Gold Standard Framework criteria20 applied retrospectively
 DNACPR, do-not-attempt cardiopulmonary resuscitation; ICU, intensive care unit; TELP, treatment escalation/limitation plan.
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highlighted in the TELP that we use (see online supple-
mentary appendix B).
Our study provides data to support the original work of 
Fritz et al.17 In that study, the reduction in harms achieved 
using the UFTO was 37% for the rate per 1000 patient 
days. This compares with 77% in the present study. The 
methodologies differ between the studies. In the study 
by Fritz et al, the Global Trigger Tool was used to iden-
tify harms,26 27 whereas we used the SJRM.18 The nature 
and threshold for harms identification may be different 
between the two methods, but the overall pattern of 
outcomes and conclusions are similar.
In an important review, Fritz has emphasised that 
discussions and decisions about resuscitation should 
incorporate broader goals of care and proceed towards a 
TELP.13 We agree, and our findings strongly support this 
recommendation. Although particularly useful in patients 
identified to be on an end-of-life trajectory, the TELP tool 
should be used to guide the management of clinical dete-
rioration in any patient with critical illness. The scope of a 
TELP encompasses a broad range of intervention options 
rather than just a single one such as CPR. The availability 
of a TELP encourages earlier, more meaningful conversa-
tions with patients and their families, and also facilitates 
improved levels of communication between on-call staff 
out-of-hours and at handovers.28
Our study has several weaknesses. Given the nature of 
the hospital record review process, it was not possible 
to blind reviewers as to whether a patient had a TELP, 
a DNACPR order or neither, given that this informa-
tion was always referred to in patients’ notes. Two of the 
authors (CJL and DRT) have been extensively involved 
with the development and implementation of the TELP. 
We accept that these reviewers may have been biased 
towards finding problems in the group of patients who 
did not have a TELP. We attempted to mitigate this by 
cross-checking data obtained by all four reviewers and 
the inter-rater correlations were high (ĸ values 0.74 to 
0.85.) Our study was retrospective and based in a single 
centre during late winter and spring. Seasonal factors, 
notably workloads and bed availability may have resulted 
in delayed recognition of prognosis or actioning of a 
TELP. It did not address the effectiveness of the TELP 
in critically ill patients who were subsequently discharged 
from hospital. Obtaining data in this group would enable 
assessment of whether the benefits of the TELP are more 
generalisable.
In conclusion, our study provides evidence that antic-
ipatory planning for patients who are critically ill, and 
in particular the use of a TELP to communicate such a 
plan, is an important contributor to reducing harms in 
hospital. The mechanism whereby a TELP plays a part 
in medical decision-making is complex but includes a 
reduction in clinicians choosing NBIs. The process of 
identifying the illness trajectory, setting agreed goals 
of treatment and using an appropriate communication 
tool to ensure continuity of care was often late rather 
than timely in the care of critically ill or dying patients T
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in our hospital. Considering and discussing these issues 
on admission to hospital and using a TELP earlier during 
admission to hospital have the potential to contribute to 
improved patient care. The outcome of studies including 
the development of the Recommended Summary Plan 
for Emergency Care and Treatment (ReSPECT) tool will 
be important.16
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